Literature DB >> 17646271

Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families.

Jeffrey N Weitzel1, Veronica I Lagos, Josef S Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S Ho, Charité N Ricker, Katrina J Lowstuter, Kathleen R Blazer, Gail Tomlinson, Tom Scholl.   

Abstract

BACKGROUND: Large rearrangements account for 8% to 15% of deleterious BRCA mutations, although none have been characterized previously in individuals of Mexican ancestry.
METHODS: DNA from 106 Hispanic patients without an identifiable BRCA mutation by exonic sequence analysis was subjected to multiplexed quantitative differential PCR. One case of Native American and African American ancestry was identified via multiplex ligation-dependent probe amplification. Long-range PCR was used to confirm deletion events and to clone and sequence genomic breakpoints. Splicing patterns were derived by sequencing cDNA from reverse transcription-PCR of lymphoblastoid cell line RNA. Haplotype analysis was conducted for recurrent mutations.
RESULTS: The same deletion of BRCA1 exons 9 through 12 was identified in five unrelated families. Long-range PCR and sequencing indicated a deletion event of 14.7 kb. A 3-primer PCR assay was designed based on the deletion breakpoints, identified within an AluSp element in intron 8 and an AluSx element in intron 12. Haplotype analysis confirmed common ancestry. Analysis of cDNA showed direct splicing of exons 8 to 13, resulting in a frameshift mutation and predicted truncation of the BRCA1 protein.
CONCLUSIONS: We identified and characterized a novel large BRCA1 deletion in five unrelated families-four of Mexican ancestry and one of African and Native American ancestry, suggesting the possibility of founder effect of Amerindian or Mestizo origin. This BRCA1 rearrangement was detected in 3.8% (4 of 106) of BRCA sequence-negative Hispanic families. An assay for this mutation should be considered for sequence-negative high-risk Hispanic patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646271     DOI: 10.1158/1055-9965.EPI-07-0198

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  45 in total

1.  Developing strategies for reducing cancer disparities via cross-institutional collaboration: outreach efforts for the partnership between the Ponce School of Medicine and the Moffitt Cancer Center.

Authors:  Clement K Gwede; Eida Castro; Thomas H Brandon; Jessica McIntyre; Cathy D Meade; Teresita Munoz-Antonia; Vani N Simmons; Susan T Vadaparampil; Julio Jimenez; Gwendolyn P Quinn
Journal:  Health Promot Pract       Date:  2011-12-12

Review 2.  A review of cancer in U.S. Hispanic populations.

Authors:  Robert W Haile; Esther M John; A Joan Levine; Victoria K Cortessis; Jennifer B Unger; Melissa Gonzales; Elad Ziv; Patricia Thompson; Donna Spruijt-Metz; Katherine L Tucker; Jonine L Bernstein; Thomas E Rohan; Gloria Y F Ho; Melissa L Bondy; Maria Elena Martinez; Linda Cook; Mariana C Stern; Marcia Cruz Correa; Jonelle Wright; Seth J Schwartz; Lourdes Baezconde-Garbanati; Victoria Blinder; Patricia Miranda; Richard Hayes; George Friedman-Jiménez; Kristine R Monroe; Christopher A Haiman; Brian E Henderson; Duncan C Thomas; Paolo Boffetta
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

3.  Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.

Authors:  J Abugattas; M Llacuachaqui; Y Sullcahuaman Allende; A Arias Velásquez; R Velarde; J Cotrina; M Garcés; M León; G Calderón; M de la Cruz; P Mora; R Royer; J Herzog; J N Weitzel; S A Narod
Journal:  Clin Genet       Date:  2014-10-28       Impact factor: 4.438

4.  Clinical and pathological characteristics of Hispanic BRCA-associated breast cancers in the American-Mexican border city of El Paso, TX.

Authors:  Zeina Nahleh; Salman Otoukesh; Alok Kumar Dwivedi; Indika Mallawaarachchi; Luis Sanchez; J Salvador Saldivar; Kayla Cataneda; Rosalinda Heydarian
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

5.  Important considerations for recruiting women to cancer genetics studies in Puerto Rico.

Authors:  Euna M August; Gwen P Quinn; Rossybelle Perales; Zuheily Closser; Julie Dutil; Marieva Puig; Susan T Vadaparampil
Journal:  J Cancer Educ       Date:  2012-03       Impact factor: 2.037

6.  A pilot study of knowledge and interest of genetic counseling and testing for hereditary breast and ovarian cancer syndrome among Puerto Rican women.

Authors:  Susan T Vadaparampil; Gwendolyn P Quinn; Julie Dutil; Marieva Puig; Teri L Malo; Jessica McIntyre; Rossybelle Perales; Euna M August; Zuheily Closser
Journal:  J Community Genet       Date:  2011-07-12

7.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

Review 8.  Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups.

Authors:  Tejal A Patel; Gerardo Colon-Otero; Celyne Bueno Hume; John A Copland; Edith A Perez
Journal:  Oncologist       Date:  2010-04-28

9.  Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Authors:  Jeffrey N Weitzel; Jessica Clague; Arelis Martir-Negron; Raquel Ogaz; Josef Herzog; Charité Ricker; Chelsy Jungbluth; Cheryl Cina; Paul Duncan; Gary Unzeitig; J Salvador Saldivar; Mary Beattie; Nancy Feldman; Sharon Sand; Danielle Port; Deborah I Barragan; Esther M John; Susan L Neuhausen; Garrett P Larson
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

10.  A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancer.

Authors:  Susan T Vadaparampil; Gwendolyn P Quinn; Brent J Small; Jessica McIntyre; Claudia Aguado Loi; Zuheily Closser; Clement K Gwede
Journal:  Genet Test Mol Biomarkers       Date:  2010-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.